PTX3 and coronary artery disorder: In nine studies, published between 2004 and 2017, among adult study populations conducted in Asia, Europe, and North America, there seems to be a consensus that patients with coronary disease and higher circulating PTX-3 levels had an increased risk of all-cause mortality, cardiac death, and cardiac events (26).